Roche launches system to advance sequencing technologies

Roche has launched the AVENIO Edge System, a core component of Roche’s strategy to advance sequencing technologies. Built on best-in-class foundational capabilities to deliver a fully-automated, integrated sequencing solution, it said in a press release Monday.

The AVENIO Edge System is a pre-analytical platform for sequencing library preparation, target enrichment and quantification steps that deliver integrated, end-to-end control with reliable, consistent high-quality results, Roche noted.

Thomas Schinecker, CEO Roche Diagnostics said Roche is committed to developing diagnostic solutions with the goal of providing the healthcare community with faster and more accurate medical information to predict risk and detect disease. “We are pleased to offer next-generation sequencing laboratories and translational researchers the new automated Avenio Edge System that aims to drastically reduce human error and help ensure fast, reliable and accurate results,” he said.